Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors.

Saved in:
Bibliographic Details
Title: Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors.
Authors: Chen, Yunching, Liu, Ya-Chi1, Sung, Yun-Chieh1, Ramjiawan, Rakesh R., Lin, Ts-Ting1, Chang, Chih-Chun1, Jeng, Kuo-Shyang2, Chang, Chiung-Fang2, Liu, Chun-Hung1, Gao, Dong-Yu1, Hsu, Fu-Fei3, Duyverman, Annique M., Kitahara, Shuji4, Huang, Peigen4, Dima, Simona5, Popescu, Irinel5, Flaherty, Keith T.6, Zhu, Andrew X.6, Bardeesy, Nabeel6, Jain, Rakesh K.4
Source: Scientific Reports. 3/10/2017, p44123. 1p.
Database: Academic Search Ultimate
Description
ISSN:20452322
DOI:10.1038/srep44123